Pharmaceutical Technology on MSN
MHRA approves Roche’s inavolisib for breast cancer
The approval enables the use of inavolisib in patients whose cancer has recurred during or after hormone therapy and has ...
Based on formulation simplicity and blinding capability, hard gelatin capsules are preferrable compared with other oral solid dosage forms, including tablets, in the early clinical phases of drug ...
Effective design of the tablet core and the coating process can help prevent film coating problems. Film coatings on pharmaceutical tablets provide a broad range of functionalities, and the coating ...
The MHRA has approved inavolisib for adults with PIK3CA-mutated HR+/HER2– breast cancer, offering a new targeted first-line ...
Fast, precise, adaptable, and sustainable - L.B. Bohle’s current edition of the BFC tablet coater is not only a technologically advanced tablet coater but also an exceptionally designed film coater. L ...
Tablets are the most used oral dose type in the pharmaceutical sector. They have numerous benefits, the most important of which are their capacity to precisely manage dosage and the great stability of ...
Indoco announced that its subsidiary company, Indoco Remedies UK Limited, officially launched Ticagrelor film-coated tablets 90 mg in the United Kingdom on June 2, 2025. This significant addition to ...
The individual mechanism of action of each component contributes to the FDC's efficacy in hypertension management. Amlodipine, by blocking voltage-dependent L-type calcium channels, induces ...
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) yesterday approved Swiss pharma giant Roche’s Itovebi ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results